BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Topics
»
Regulatory
» EMA
EMA
RSS
CHMP issues positive opinion for Baxter's Celvapan H1N1 pandemic influenza vaccine
Oct. 6, 2009
E.C. approves Novartis' Focetria vaccine for use in the H1N1 influenza pandemic
Oct. 1, 2009
EMEA withdraws marketing authorization for Posaconazole SP
Aug. 7, 2009
GlaxoSmithKline withdraws MAA for Bosatria
Aug. 3, 2009
European CHMP recommends marketing authorization for Tigenix's ChondroCelect
July 2, 2009
CHMP adopts positive opinion for Otsuka's Samsca in hyponatremia
June 12, 2009
CHMP recommends granting of marketing authorization for Orphan Europe's Vedrop
June 11, 2009
EMEA provides information on possible interaction between clopidogrel and PPIs
June 9, 2009
Sepracor withdraws marketing authorization application for Lunivia (eszopiclone)
May 19, 2009
The European Commission withdraws marketing authorization for Velosulin
April 20, 2009
Previous
1
2
…
148
149
150
151
152
153
154
155
156
157
158
159
Next
RSS